Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of... by Kwakman, J.J.M, Simkens, L.H.J, Van Rooijen, J.M, Van de Wouw, A.J, Loosveld, O.J.L, Creemers, G.J.M, Hendriks, M.P, Los, M, Van Alphen, R.J, Polée, M.B, Muller, E.W, Van der Velden, A.M.T, Van Voorthuizen, T, Koopman, M, Mol, L, Van Werkhoven, E, Punt, C.J.A

Get full text

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospectiv... by Osterlund, P., Kinos, S., Pfeiffer, P., Salminen, T., Kwakman, J.J.M., Frödin, J.-E., Shah, C.H., Sorbye, H., Ristamäki, R., Halonen, P., Soveri, L.M., Heervä, E., Ålgars, A., Bärlund, M., Hagman, H., McDermott, R., O’Reilly, M., Röckert, R., Liposits, G., Kallio, R., Flygare, P., Teske, A.J., van Werkhoven, E., Punt, C.J.A., Glimelius, B.

Get full text

2BA - Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO stu... by Kwakman, J.J.M., Simkens, L.H.J., Van Rooijen, J.M., Van de Wouw, A.J., Loosveld, O.J.L., Creemers, G.J.M., Hendriks, M.P., Los, M., Van Alphen, R.J., Polée, M.B., Muller, E.W., Van der Velden, A.M.T., Van Voorthuizen, T., Koopman, M., Mol, L., Van Werkhoven, E., Punt, C.J.A.

Get full text

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospectiv... by Osterlund, P, Kinos, S, Pfeiffer, P, Salminen, T, Kwakman, J.J.M, Frödin, J.-E, Shah, C.H, Sorbye, Halfdan, Ristamäki, R, Halonen, P, Soveri, L.M, Heervä, E, Ålgars, A, Bärlund, M, Hagman, H, McDermott, R, O'Reilly, M, Röckert, R, Liposits, G, Kallio, R, Flygare, P, Teske, A.J, van Werkhoven, Werkhoven, Punt, C.J.A, Glimelius, B

Request full text